Abstract
A number of intracranial tumors demonstrate some degree of enlargement after stereotactic radiosurgery (SRS). It necessitates differentiation of their regrowth and various treatment-induced effects. Introduction of low-dose standards for SRS of benign neoplasms significantly decreased the risk of the radiation-induced necrosis after management of schwannomas and meningiomas. Although in such cases a transient increase of the mass volume within several months after irradiation is rather common, it usually followed by spontaneous shrinkage. Nevertheless, distinguishing tumor recurrence from radiation injury is often required in cases of malignant parenchymal brain neoplasms, such as metastases and gliomas. The diagnosis is frequently complicated by histopathological heterogeneity of the lesion with coexistent viable tumor and treatment-related changes. Several neuroimaging modalities, namely structural magnetic resonance imaging (MRI), diffusion-weighted imaging, diffusion tensor imaging, perfusion computed tomography (CT) and MRI, single-voxel and multivoxel proton magnetic resonance spectroscopy as well as single photon emission CT and positron emission tomography with various radioisotope tracers, may provide valuable diagnostic information. Each of these methods has advantages and limitations that may influence its usefulness and accuracy. Therefore, use of a multimodal radiological approach seems reasonable. Addition of functional and metabolic neuroimaging to regular structural MRI investigations during follow-up after SRS of parenchymal brain neoplasms may permit detailed evaluation of the treatment effects and early prediction of the response. If tissue sampling of irradiated intracranial lesions is required, it is preferably performed with the use of metabolic guidance. In conclusion, differentiation of tumor progression and radiation-induced effects after intracranial SRS is challenging. It should be based on a complex evaluation of the multiple clinical, radiosurgical, and radiological factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, Kochi M, Morishita S, Yamashita Y (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 26:1455–1460
Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, Cha S (2009) Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following Gamma Knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 30:367–372
Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC (2010) Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 77:996–1001
Brismar J, Roberson GH, Davis KR (1976) Radiation necrosis of the brain. Neuroradiological considerations with computed tomography. Neuroradiology 12:109–113
Castel JC, Caille JM (1989) Imaging of irradiated brain tumours: value of magnetic resonance imaging. J Neuroradiol 16:81–132
Chao ST, Suh JH, Raja S, Lee SY, Barnett G (2001) The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery. Int J Cancer 96:191–197
Chen HI, Burnett MG, Huse JT, Lustig RA, Bagley LJ, Zager EL (2006) Recurrent late cerebral necrosis with aggressive characteristics after radiosurgical treatment of an arteriovenous malformation. J Neurosurg 105:455–460
Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47:904–911
Chernov MF, Hayashi M, Izawa M, Nakaya K, Tamura N, Ono Y, Abe K, Usukura M, Yoshida S, Nakamura R, Suzuki T, Muragaki Y, Iseki H, Kubo O, Hori T, Takakura K (2009) Dynamics of metabolic changes in intracranial metastases and distant normal-appearing brain tissue after stereotactic radiosurgery: a serial proton magnetic resonance spectroscopy study. Neuroradiol J 22:58–71
Chernov M, Hayashi M, Izawa M, Nakaya K, Ono Y, Usukura M, Yoshida S, Kato K, Muragaki Y, Nakamura R, Iseki H, Hori T, Takakura K (2007) Metabolic characteristics of intracranial metastases, detected by single-voxel proton magnetic resonance spectroscopy, are seemingly not predictive for tumor response to gamma knife radiosurgery. Minim Invasive Neurosurg 50:233–238
Chernov MF, Hayashi M, Izawa M, Ochiai T, Usukura M, Abe K, Ono Y, Muragaki Y, Kubo O, Hori T, Takakura K (2005) Differentiation of the radiation-induced necrosis and tumor recurrence after Gamma Knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. Minim Invasive Neurosurg 48:228–234
Chernov MF, Hayashi M, Izawa M, Usukura M, Yoshida S, Ono Y, Muragaki Y, Kubo O, Hori T, Takakura K (2006) Multivoxel proton MRS for differentiation of radiation-induced necrosis and tumor recurrence after Gamma Knife radiosurgery for brain metastases. Brain Tumor Pathol 23:19–27
Chin LS, Ma L, DiBiase S (2001) Radiation necrosis following Gamma Knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow-up. J Neurosurg 94:899–904
Couldwell WT, Cole CD, Al-Mefty O (2007) Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg 106:30–35
Delsanti C, Roche PH, Thomassin JM, Regis J (2008) Morphological changes of vestibular schwannomas after radiosurgical treatment: pitfalls and diagnosis of failure. In: Regis J, Roche PH (eds) Modern Management of Acoustic Neuroma. Prog Neurol Surg, vol. 21. Karger, Basel, pp 93–97
Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898–904
Essig M, Waschkies M, Wenz F, Debus J, Hentrich HR, Knopp MV (2003) Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology 228:193–199
Feigl GC, Horstmann GA (2006) Volumetric follow up of brain metastases: a useful method to evaluate treatment outcome and predict survival after Gamma Knife surgery? J Neurosurg 105(Suppl):91–98
Feigl GC, Samii M, Horstman GA (2007) Volumetric follow-up of meningiomas: a quantitative method to evaluate treatment outcome of gamma knife radiosurgery. Neurosurgery 61:281–287
Foroughi M, Kemeny AA, Lehecka M, Wons J, Kajdi L, Hatfield R, Marks S (2010) Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations – case analysis and literature review. Acta Neurochir (Wien) 152:803–815
Ganz JC, Reda WA, Abdelkarim K (2009) Adverse radiation effects after Gamma Knife surgery in relation to dose and volume. Acta Neurochir (Wien) 151:9–19
Gao X, Zhang XN, Zhang YT, Yu CS, Xu DS (2011) Magnetic resonance imaging in assessment of treatment response of Gamma Knife for brain tumors. Chin Med J (Engl) 124:1906–1910
Goldman M, Boxerman JL, Rogg JM, Noren G (2006) Utility of apparent diffusion coefficient in predicting the outcome of gamma knife-treated brain metastases prior to changes in tumor volume: a preliminary study. J Neurosurg 105(Suppl):175–182
Hasegawa T, Kida Y, Yoshimoto M, Koike J, Goto K (2006) Evaluation of tumor expansion after stereotactic radiosurgery in patients harboring vestibular schwannomas. Neurosurgery 58:1119–1128
Herholz K, Coope D, Jackson A (2007) Metabolic and molecular imaging in neuro-oncology. Lancet Neurol 6:711–724
Hirato M, Hirato J, Zama A, Inoue H, Ohye C, Shibazaki T, Andou Y (1996) Radiobiological effects of gamma knife radiosurgery on brain tumors studied in autopsy and surgical specimens. Stereotact Funct Neurosurg 66(Suppl 1):4–16
Hoefnagels FWA, Lagerwaard FJ, Sanchez E, Haasbeek CJA, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887
Hong IK, Kim JH, Ra YS, Kwon DH, Oh SJ, Kim JS (2011) Diagnostic usefulness of 3′-deoxy-3′-[18F] fluorothymidine positron emission tomography in recurrent brain tumor. J Comput Assist Tomogr 35:679–684
Horky LL, Hsiao EM, Weiss SE, Drappatz J, Gerbaudo VH (2011) Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis. J Neurooncol 103:137–146
Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D, Richey K, Park S, Pieper DR, Chen PY, Grills IS (2011) Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Magn Reson Imaging 29:993–1001
Huang CF, Chou HH, Tu HT, Yang MS, Lee JK, Lin LY (2008) Diffusion magnetic resonance imaging as an evaluation of the response of brain metastases treated by stereotactic radiosurgery. Surg Neurol 69:62–68
Jagannathan J, Bourne TD, Schlesinger D, Yen CP, Shaffrey ME, Laws ER Jr, Sheehan JP (2010) Clinical and pathological characteristics of brain metastases resected after failed radiosurgery. Neurosurgery 66:208–217
Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S, Rock JP, Rosenblum M, Gutierrez J, Mikkelsen T (2011) Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors? AJNR Am J Neuroradiol 32:658–663
Jain R, Narang J, Sundgren PM, Hearshen D, Saksena S, Rock JP, Gutierrez J, Mikkelsen T (2010) Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging. J Neurooncol 100:17–29
Jain R, Scarpace L, Ellika S, Schultz LR, Rock JP, Rosenblum ML, Patel SC, Lee TY, Mikkelsen T (2007) First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 61:778–787
Jandial R, Duenas VJ, Chen BT (2011) Molecular imaging based on differential protein content in differentiating glioma from radiation necrosis. Neurosurgery 68(6):N16–N17
Jennelle R, Gladson C, Palmer C, Guthrie B, Markert J (1999) Paradoxical labeling of radiosurgically treated quiescent tumors with Ki 67, a marker of cellular proliferation. Stereotact Funct Neurosurg 72(Suppl 1):45–52
Kamada K, Mastuo T, Tani M, Izumo T, Suzuki Y, Okimoto T, Hayashi N, Hyashi K, Shibata S (2001) Effects of stereotactic radiosurgery on metastatic brain tumors of various histopahtologies. Neuropathology 21:307–314
Kang TW, Kim ST, Byun HS, Jeon P, Kim K, Kim H, Lee J II (2009) Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72:370–380
Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) Differentiating radiation effect from tumor progression after stereotactic radiosurgery: T1/T2 matching. Clin Neurosurg 57:160–165
Kano H, Kondziolka D, Lobato-Polo J, Zorro O, Flickinger JC, Lunsford LD (2010) T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Neurosurgery 66:486–492
Kihlstrom L, Karlsson B (1999) Imaging changes after radiosurgery for vascular malformations, functional targets and tumors. Neurosurg Clin N Am 10:167–180
Kimura T, Sako K, Tanaka K, Gotoh T, Yoshida H, Aburano T, Tanaka T, Arai H, Nakada T (2004) Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg 100:835–841
Kimura T, Sako K, Tohyama Y, Aizawa S, Yoshida H, Aburano T, Tanaka K, Tanaka T (2003) Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastases: value of proton magnetic resonance spectroscopy. Acta Neurochir (Wien) 145:557–564
Kingsley DP, Kendall BE (1981) CT of the adverse effects of therapeutic radiation of the Central Nervous System. AJNR Am J Neuroradiol 2:453–460
Kizu O, Naruse S, Furuya S, Morishita H, Ide M, Maeda T, Ueda S (1998) Application of proton chemical shift imaging in monitoring of gamma knife radiosurgery on brain tumors. Magn Reson Imaging 16:197–204
Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB (2006) 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 64:419–424
Kubo O, Chernov M, Izawa M, Hayashi M, Muragaki Y, Maruyama T, Hori T, Takakura K (2005) Malignant progression of benign brain tumors after gamma knife radiosurgery: is it really caused by irradiation? Minim Invasive Neurosurg 48:334–339
Kwock L, Smith JK, Castillo M, Ewend MG, Cush S, Hensing T, Varia M, Morris D, Bouldin TW (2002) Clinical applications of proton MR spectroscopy in oncology. Technol Cancer Res Treat 1:17–28
Langleben DD, Segall GM (2000) PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41:1861–1867
Lee PL, Gonzalez RG (2000) Magnetic resonance spectroscopy of brain tumors. Curr Opin Oncol 12:199–204
Liu RS, Chang CP, Guo WY, Pan DHC, Ho DMT, Chang CW, Yang BH, Wu LC, Yeh SH (2010) 1-11C-Acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery. J Nucl Med 51:883–891
Loeffler JS, Niemierko A, Chapman PH (2003) Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery 52:1436–1442
Lunsford LD, Kondziolka D, Maitz A, Flickinger JC (1998) Black holes, white dwarfs and supernovas: imaging after radiosurgery. Stereotact Funct Neurosurg 70(Suppl 1):2–10
Lunsford LD, Niranjan A, Martin J, Sirin S, Kassam A, Kondziolka D, Flickinger JC (2007) Radiosurgery for miscellaneous skull base tumors. In: Szeifert GT, Kondziolka D, Levivier M, Lunsford LD (eds) Radiosurgery and Pathological Fundamentals. Prog Neurol Surg, vol. 20. Karger, Basel, pp 192–205
Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E, Okawa H, Furukawa Y, Hirai T, Endo M (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99:81–88
Mullins ME, Barest GD, Schaefer PW, Hochberg FH, Gonzalez RG, Lev MH (2005) Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 26:1967–1972
Niranjan A, Kondziolka D, Lunsford LD (2009) Neoplastic transformation after radiosurgery or radiotherapy: risk and realties. Otolaryngol Clin North Am 42:717–729
Padhani AR, Miles KA (2010) Multiparametric imaging of tumor response to therapy. Radiology 256:348–364
Palumbo B (2008) Brain tumour recurrence: brain single-photon emission computerized tomography, PET and proton magnetic resonance spectroscopy. Nucl Med Commun 29:730–735
Pamir MN, Kilic T, Belirgen M, Abacioglu U, Karabekiroglu N (2007) Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61:270–280
Pan DHC, Guo WY, Chung WY, Shiau CY, Liu RS, Lee LS (1995) Early effects of gamma knife surgery on malignant and benign intracranial tumors. Stereotact Funct Neurosurg 64(Suppl 1):19–31
Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JPS, Chiang VL (2011) A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases. AJNR Am J Neuroradiol 32:1885–1892
Plowman PN (1999) Stereotactic radiosurgery VIII. The classification of postirradiation reactions. Br J Neurosurg 13:256–264
Pollock BE (2006) Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 58:241–248
Pruzincova L, Steno J, Srbecky M, Kalina P, Rychly B, Boljesikova E, Chorvath M, Novotny M, Procka V, Makaiova I, Belan V (2009) MR imaging of late radiation therapy- and chemotherapy-induced injury: a pictorial essay. Eur Radiol 19:2716–2727
Rachinger W, Goetz C, Popperl G, Gildehaus FJ, Kreth FW, Holtmannspotter M, Herms J, Koch W, Tatsch K, Tonn JC (2005) Positron emission tomography with O-(2-[18F]fluoroethyl)-l-Tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery 57:505–511
Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T (2002) Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 51:912–920
Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54:1111–1119
Rogers LR, Gutierrez J, Scarpace L, Schultz L, Ryu S, Lord B, Movsas B, Nonsowetz J, Jain R (2011) Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis. J Neurooncol 101:25–32
Ross DA, Sandler HM, Balter JM, Hayman JA, Archer PG, Auer DL (2002) Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 56:175–181
Rowe J, Grainger A, Walton L, Silcocks P, Radatz M, Kemeny A (2007) Risk of malignancy after gamma knife stereotactic radiosurgery. Neurosurgery 60:60–66
Seo YS, Chung TW, Kim IY, Bom HS, Min JJ (2008) Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET. Clin Nucl Med 33:32–33
Serizawa T, Saeki N, Higuchi Y, Ono J, Matsuda S, Sato M, Yanagisawa M, Iuchi T, Nagano O, Yamaura A (2005) Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after Gamma Knife surgery for metastatic brain tumors. J Neurosurg 102(Suppl):266–271
Sundgren PC, Fan X, Weybright P, Welsh RC, Carlos RC, Petrou M, McKeever PE, Chenevert TL (2006) Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 24:1131–1142
Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K (2008) Diagnostic accuracy of 11C-Methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. J Nucl Med 49:694–699
Tomura N, Izumi J, Anbai A, Takahashi S, Sakuma I, Omachi K, Kidani H, Sasaki K, Watarai J, Suzuki A, Mizoi K (2005) Thallium-201 SPECT in the evaluation of early effects on brain tumors treated with stereotactic irradiation. Clin Nucl Med 30:83–86
Tomura N, Narita K, Izumi JI, Suzuki A, Anbai A, Otani T, Sakuma I, Takahashi S, Mizoi K, Watarai J (2006) Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response. J Comput Assist Tomogr 30:496–500
Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M (2003) Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98:1056–1064
Vos MJ, Tony BN, Hoekstra OS, Postma TJ, Heimans JJ, Hooft L (2007) Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun 28:431–439
Wang SX, Boethius J, Ericson K (2006) FDG-PET on irradiated brain tumor: ten years’ summary. Acta Radiol 47:85–90
Weber MA, Lichy MP, Thilmann C, Gunther M, Bachert P, Maudsley AA, Delorme S, Schad LR, Debus J, Schlemmer HP (2003) Monitoring of irradiated brain metastases using MR perfusion imaging and 1H MR spectroscopy. Radiologe 43:388–395 (in German)
Weber MA, Thilmann C, Lichy MP, Gunther M, Delorme S, Zuna I, Bongers A, Schad LR, Debus J, Kauczor HU, Essig M, Schlemmer HP (2004) Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 39:277–287
Young GS (2007) Advanced MRI of adult brain tumors. Neurol Clin 25:947–973
Yoshino E, Ohmori Y, Imahori Y, Higuchi T, Furuya S, Naruse S, Mori T, Suzuki K, Yamaki T, Ueda S, Tsuzuki T, Takai S (1996) Irradaition effects on the metabolism of metastatic brain tumors: analysis by positron emission tomography and 1H-magnetic resonance spectroscopy. Stereotact Funct Neurosurg 66(Suppl 1):240–259
Zada G, Pagnini PG, Yu C, Erickson KT, Hirschbein J, Zelman V, Apuzzo MLJ (2010) Long-term outcomes and patterns of tumor progression after gamma knife radiosurgery for benign meningiomas. Neurosurgery 67:322–329
Conflict of Interest
The authors declare that they have no conflict of interest. The research activities of Dr. Mikhail Chernov during 2010–2012 were supported by the Japan Society for the Promotion of Science (JSPS; ID No. P 10128).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this paper
Cite this paper
Chernov, M.F. et al. (2013). Differentiation of Tumor Progression and Radiation-Induced Effects After Intracranial Radiosurgery. In: Chernov, M., Hayashi, M., Ganz, J., Takakura, K. (eds) Gamma Knife Neurosurgery in the Management of Intracranial Disorders. Acta Neurochirurgica Supplement, vol 116. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1376-9_29
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1376-9_29
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1375-2
Online ISBN: 978-3-7091-1376-9
eBook Packages: MedicineMedicine (R0)